---
category: news
title: "Avalon GloboCare advances its AI-enhanced protein design technology for cellular therapy development in collaboration with MIT"
excerpt: "The researchers used the QTY code technology to design water-soluble versions of chemokine receptorsâ€”water-insoluble proteins involved"
publishedDateTime: 2021-12-09T14:20:00Z
originalUrl: "https://www.proactiveinvestors.com/companies/news/968784/avalon-globocare-advances-its-ai-enhanced-protein-design-technology-for-cellular-therapy-development-in-collaboration-with-mit-968784.html"
webUrl: "https://www.proactiveinvestors.com/companies/news/968784/avalon-globocare-advances-its-ai-enhanced-protein-design-technology-for-cellular-therapy-development-in-collaboration-with-mit-968784.html"
ampWebUrl: "https://www.proactiveinvestors.com/companies/amp/news/968784"
cdnAmpWebUrl: "https://www-proactiveinvestors-com.cdn.ampproject.org/c/s/www.proactiveinvestors.com/companies/amp/news/968784"
type: article
quality: 46
heat: 46
published: false

provider:
  name: Proactiveinvestors
  domain: proactiveinvestors.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.proactiveinvestors.com//thumbs/upload/News/Image/2021_12/1200z740_1639060784_shutterstock_530971462.jpg"
    width: 1200
    height: 740
    isCached: true

secured: "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;mVwpYWpUyY6gjR1tqeJApw=="
---

